Hong Kong Training Portal on
Infection Control and Infectious Disease

Progress towards elimination goals for viral hepatitis (23 July 2020)

Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission (February 2019)

Hepatitis A

• Hepatitis A Virus Genotype IB Outbreak among Internally Displaced Persons, Syria (January 20, 2020)
• Hepatitis A: the changing epidemiology of hepatitis A. Clinical liver disease. (2013 Dec).
• Hepatitis A. (2012 Dec 1).
• Hepatitis A: clinical manifestations and management. (2010).

Hepatitis B

• Update on Prevention, Diagnosis, and Treatment of Chronic Hepatitis B: AASLD 2018 Hepatitis B Guidance (April 2018)
• Tenofovir alafenamide: a review in chronic hepatitis B. (2017 Jun 1).
• European Association For The Study Of The Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. (2017 Aug 1).
• AASLD guidelines for treatment of chronic hepatitis B. (2016 Jan 1).
• Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta‐analysis. (2016 Jan 1).
• Antiviral therapy in chronic hepatitis B viral infection during pregnancy: a systematic review and meta‐analysis. (2016 Jan 1)
• Antiviral therapy in management of chronic hepatitis B viral infection in children: A systematic review and meta‐analysis.(2016 Jan 1)
• Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities. (2015 Sep 1).
• Hepatitis B virus infection. (2014 Dec 6).

Hepatitis B Local Research

• Prevalence of fibrosis and cirrhosis in chronic hepatitis B: implications for treatment and management. (2008 Jun).

Hepatitis C

• IDSA - HCV: Hepatitis C Virus
• Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection (09 Dec 2019)
• Hepatitis C (Lancet) (October 19, 2019)
• Hepatitis C: individualised medicine versus one pill fits all. (2016 Oct 1).
• Global distribution and prevalence of hepatitis C virus genotypes. (2015 Jan 1).
• EASL recommendations on treatment of hepatitis C 2015. (2015 Jul 1)
• Simple, effective, but out of reach? Public health implications of HCV drugs. (2015 Dec 31)
• Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. (2014 Jan 1).
• Treatment of hepatitis C: a systematic review. (2014 Aug 13).
• Diagnosis, management, and treatment of hepatitis C: an update. (2009 Apr 1).

Hepatitis C Local Research

• Territory‐wide population‐based study of chronic hepatitis C infection and implications for hepatitis elimination in Hong Kong. (2018 Jul 7)
• Real‐life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong. (2017 Jun).
• Prevalence of hepatitis C infection in injection drug users in Hong Kong. (2009 Dec)
• Viral hepatitis C in Hong Kong. (2006).

Hepatitis D

• (2015). Hepatitis D virus: introduction and epidemiology. Cold Spring Harbor perspectives in medicine, 5(7), a021576.

Hepatitis E

• Hepatitis E virus infection during pregnancy (10 June 2020)
• The global epidemiology of hepatitis E virus infection: A systematic review and meta‐analysis (13 April 2020)
• Update on hepatitis E virology: Implications for clinical practice. (2016 Jul 1).
• Hepatitis E: an emerging global disease–from discovery towards control and cure. (2016 Feb).
• Hepatitis E virus infection. (2014 Jan 1).
• Ribavirin for chronic hepatitis E virus infection in transplant recipients. (2014 Mar 20).